Effects ofN-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects ofN-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 33, Issue 9, Pages 1324-1331
Publisher
Wiley
Online
2013-05-16
DOI
10.1111/liv.12214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvements in Hepatic Serological Biomarkers Are Associated with Clinical Benefit of Intravenous N-Acetylcysteine in Early Stage Non-Acetaminophen Acute Liver Failure
- (2013) Sundeep Singh et al. DIGESTIVE DISEASES AND SCIENCES
- Linkage of gut microbiome with cognition in hepatic encephalopathy
- (2011) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The balance between intrahepatic IL-17+ T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease
- (2011) Yinghua Niu et al. BMC IMMUNOLOGY
- Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
- (2011) Y. Tang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hepatic encephalopathy: A central neuroinflammatory disorder?
- (2011) Roger F. Butterworth HEPATOLOGY
- Neuroinflammation in acute liver failure: Mechanisms and novel therapeutic targets
- (2011) Roger F. Butterworth NEUROCHEMISTRY INTERNATIONAL
- Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression
- (2011) Li Zhao et al. PLoS One
- Th17 cells and their associated cytokines in liver diseases
- (2010) Fouad Lafdil et al. Cellular & Molecular Immunology
- Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes
- (2010) Kakulavarapu V Rama Rao et al. Journal of Neuroinflammation
- Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis
- (2010) P. A. Berry et al. LIVER INTERNATIONAL
- N-Acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms
- (2010) Chantal Bémeur et al. METABOLIC BRAIN DISEASE
- Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population
- (2009) G. Rong et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cellular mechanisms of IL-17-induced blood-brain barrier disruption
- (2009) Jula Huppert et al. FASEB JOURNAL
- Myeloid STAT3 Inhibits T Cell-Mediated Hepatitis by Regulating T Helper 1 Cytokine and Interleukin-17 Production
- (2009) Fouad Lafdil et al. GASTROENTEROLOGY
- Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure
- (2009) William M. Lee et al. GASTROENTEROLOGY
- Interleukin-17-targeted treatment of alcoholic liver disease
- (2009) Enzo Emanuele et al. HEPATOLOGY
- Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B
- (2009) Jian Ge et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- The interleukin-17 pathway is involved in human alcoholic liver disease
- (2008) Arnaud Lemmers et al. HEPATOLOGY
- The importance of immune dysfunction in determining outcome in acute liver failure
- (2008) Charalambos Gustav Antoniades et al. JOURNAL OF HEPATOLOGY
- Intensive Care Management of Acute Liver Failure
- (2008) William Bernal et al. SEMINARS IN LIVER DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started